IL6 and pulmonary arterial hypertension: In a model of transgenic mice, IL-6 was noted to induce the pathological changes seen in advanced PAH, including muscular remodeling of distal pulmonary arterioles and convolutional arteriopathy, leading to increased pulmonary resistance (PVR) and PAH.